A Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer.
Clinical trial NCT06434610 · RECRUITING
Trial details
- NCT number
- NCT06434610
- Sponsor
- Shanghai Jiaolian Drug Research and Development Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-11
- Primary completion
- 2026-12-31
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.